Free Trial

Predictive Oncology (POAI) News Today

Predictive Oncology logo
$0.69 -0.03 (-3.82%)
(As of 12/20/2024 05:45 PM ET)
Predictive Oncology downgraded to Neutral from Buy at H.C. Wainwright
H.C. Wainwright downgrades Predictive Oncology (POAI) to a Hold
Predictive Oncology Inc. Reports Q3 2024 Earnings
Predictive Discovery Advances Bankan Gold Project
Machine Learning in Predictive Toxicology
H.C. Wainwright Initiates a Buy Rating on Predictive Oncology (POAI)
S1K.BE,0P0001IOYB,0 (S1K.BE)
Q1 2024 Predictive Oncology Inc Earnings Call
Get Predictive Oncology News Delivered to You Automatically

Sign up to receive the latest news and ratings for POAI and its competitors with MarketBeat's FREE daily newsletter.

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

Register for the FREE Workshop Now & get $10 in Bitcoin

POAI Media Mentions By Week

POAI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

POAI
News Sentiment

0.00

0.60

Average
Medical
News Sentiment

POAI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

POAI Articles
This Week

0

1

POAI Articles
Average Week

Get Predictive Oncology News Delivered to You Automatically

Sign up to receive the latest news and ratings for POAI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:POAI) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners